Genenta Science S.p.A. — Form SCHEDULE 13D/A
Filed October 2, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 22/100
What the filing says
This is an amended Schedule 13D/A filing by Marco Nuzzo regarding beneficial ownership in Genenta Science S.p.A., an Italian biotech company (SIC 2836, biological products). The filing was submitted on October 2, 2026. The specific amendments, share counts, ownership percentages, and dollar amounts are not disclosed in the header information provided; the full filing document content is required to determine what beneficial ownership changed.
Why this rating
13D/A amendments are routine disclosure updates for investors crossing 5% thresholds or updating positions. Without visibility into actual ownership percentages, share counts, or whether a threshold was crossed, this appears procedural. Company size unknown but SIC 2836 biotech firms are typically small-cap, so even material stakes could be modest in absolute dollars.
See more from October 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.